These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 27056344

  • 1. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B, Lupold SE.
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [Abstract] [Full Text] [Related]

  • 2. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C, Dalton GN, Farré PL, De Luca P, De Siervi A.
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA in prostate cancer: Practical aspects.
    Patil PA, Magi-Galluzzi C.
    Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
    [Abstract] [Full Text] [Related]

  • 4. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA.
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [Abstract] [Full Text] [Related]

  • 5. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X, Foj L.
    Clin Chem Lab Med; 2017 May 01; 55(5):715-736. PubMed ID: 26751899
    [Abstract] [Full Text] [Related]

  • 6. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N, Baruah MM.
    Clin Transl Oncol; 2019 Feb 01; 21(2):126-144. PubMed ID: 29951892
    [Abstract] [Full Text] [Related]

  • 7. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.
    J Hum Genet; 2012 Nov 26; 57(11):691-9. PubMed ID: 22854542
    [Abstract] [Full Text] [Related]

  • 8. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK, Misra S, Pareek P, Mishra V, Singhal B, Sharma P.
    Urol Oncol; 2017 Mar 26; 35(3):92-101. PubMed ID: 27890424
    [Abstract] [Full Text] [Related]

  • 9. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC.
    Oncotarget; 2016 Jan 26; 7(4):3993-4008. PubMed ID: 26675257
    [Abstract] [Full Text] [Related]

  • 10. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C, Jung M, Rabenhorst S, Kilic E, Jung K.
    Clin Chem Lab Med; 2015 Jun 26; 53(7):1109-18. PubMed ID: 25720086
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-guided gene expression in prostate cancer: Literature and database overview.
    Bryzgunova OE, Konoshenko MY, Laktionov PP.
    J Gene Med; 2018 May 26; 20(5):e3016. PubMed ID: 29578262
    [Abstract] [Full Text] [Related]

  • 12. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
    Korzeniewski N, Tosev G, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S.
    Urol Oncol; 2015 Jan 26; 33(1):16.e17-16.e22. PubMed ID: 25445383
    [Abstract] [Full Text] [Related]

  • 13. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V, Lee B, Patel V, Albala D, Johansen TE, Partin A, Ross A, Perera RJ.
    Prostate Cancer Prostatic Dis; 2016 Mar 26; 19(1):14-20. PubMed ID: 26503110
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNAs Role in Prostate Cancer.
    Balacescu O, Dumitrescu RG, Marian C.
    Methods Mol Biol; 2018 Mar 26; 1856():103-117. PubMed ID: 30178248
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y.
    Int J Clin Exp Pathol; 2015 Mar 26; 8(7):8394-401. PubMed ID: 26339409
    [Abstract] [Full Text] [Related]

  • 17. microRNA in Malignant Lymphoma.
    Tagawa H.
    Adv Exp Med Biol; 2015 Mar 26; 889():41-50. PubMed ID: 26658995
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
    Goto Y, Kojima S, Nishikawa R, Kurozumi A, Kato M, Enokida H, Matsushita R, Yamazaki K, Ishida Y, Nakagawa M, Naya Y, Ichikawa T, Seki N.
    Br J Cancer; 2015 Sep 29; 113(7):1055-65. PubMed ID: 26325107
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.